Immunotherapy | Tumor

CURE’s immunotherapy page features the latest cancer news and updates on immunotherapy Through articles, videos, podcasts, and more, CURE brings readers the insights of experts, cancer survivors, patients, and advocates to ensure everyone is up to date in immunotherapy.

The Future of Immunotherapy for Bladder Cancer

March 14th 2019, 5:42pm

Video

An expert discusses the future of immunotherapy in light of new frontline treatments like Keytruda that have been demonstrating positive results for patients with non–muscle invasive bladder cancer.

The State of CAR-T Cell Therapy

March 7th 2019, 10:50pm

Article

An expert describes how far the field has come, with two treatments approved and more in the works.

Discussing the Future of Immunotherapy in Non-Small Cell Lung Cancer

February 14th 2019, 7:59pm

Article

One expert weighs in on the use of new immunotherapy agents and combinations in treating non-small cell lung cancer.

Computer Model May 'Offer Better Picture' of Who Benefits from Bladder Cancer Therapy

February 13th 2019, 8:08pm

Article

An integrative model helped to determine which patients with bladder cancer may benefit from checkpoint inhibitor therapy.

FDA Grants Priority Review to Frontline Keytruda to Treat Recurrent, Metastatic HNSCC

February 11th 2019, 7:27pm

Article

The Food and Drug Administration granted a priority review to the supplemental biologics license application for Keytruda (pembrolizumab) for the first-line treatment of patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

Clinical Trial Exclusions: Are Researchers Missing Out?

January 31st 2019, 2:05am

Article

Only about 4 percent of adults with cancer are treated on clinical trials, according to one expert. Yet, those results are then applied to everybody.

Immunotherapy Side Effects: Know the Risks

January 29th 2019, 10:24pm

Video

Immunotherapy can cause some side effects that patients and practitioners should look out for.

Immunotherapy Pair Good for Some, Not All, With Kidney Cancer

January 25th 2019, 11:21pm

Video

Yervoy plus Opdivo is a good combination for many patients with kidney cancer, though some individuals should steer clear of the regimen.

Doctor Reflects on 30 Years of Cancer History

January 19th 2019, 8:00pm

Article

When I began my medical oncology career more than 30 years ago, I was determined to be among the first generation of researchers to cure cancer.

Staying Vigilant to Manage Treatment-Related Side Effects in Kidney Cancer

January 14th 2019, 11:15pm

Article

Treatment side effects are typically manageable for patients with metastatic kidney cancer, but patients must have open communication with their health care team about them.